Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region

NCT02119780 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region

Interventions

DEVICE: YVOIRE® contour
DEVICE: Restylane SubQ™

Sponsor

LG Life Sciences